WE
AVDL
Wealth Effects’s Avadel Pharmaceuticals AVDL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.8M | Sell |
2,354,822
-14,300
| -0.6% | -$127K | 7.8% | 2 |
|
|
2025
Q1 | $18.6M | Buy |
2,369,122
+24,992
| +1% | +$196K | 7.79% | 3 |
|
|
2024
Q4 | $24.6M | Buy |
2,344,130
+110,359
| +5% | +$1.16M | 8.75% | 2 |
|
|
2024
Q3 | $29.3M | Sell |
2,233,771
-34,084
| -2% | -$447K | 10.26% | 1 |
|
|
2024
Q2 | $31.9M | Buy |
2,267,855
+3,629
| +0.2% | +$51K | 11.56% | 1 |
|
|
2024
Q1 | $38.2M | Sell |
2,264,226
-152,100
| -6% | -$2.57M | 14.11% | 1 |
|
|
2023
Q4 | $34.1M | Buy |
2,416,326
+7,037
| +0.3% | +$99.4K | 12.83% | 1 |
|
|
2023
Q3 | $24.8M | Buy |
2,409,289
+40,200
| +2% | +$414K | 12.25% | 1 |
|
|
2023
Q2 | $39M | Sell |
2,369,089
-129,749
| -5% | -$2.14M | 17.18% | 1 |
|
|
2023
Q1 | $22.9M | Sell |
2,498,838
-16,067
| -0.6% | -$147K | 11.72% | 1 |
|
|
2022
Q4 | $18M | Sell |
2,514,905
-79,855
| -3% | -$572K | 10.28% | 1 |
|
|
2022
Q3 | $13M | Buy |
2,594,760
+10,670
| +0.4% | +$53.5K | 7.95% | 2 |
|
|
2022
Q2 | $6.31M | Buy |
2,584,090
+206,800
| +9% | +$505K | 3.79% | 3 |
|
|
2022
Q1 | $16.2M | Buy |
2,377,290
+72,273
| +3% | +$494K | 7.58% | 2 |
|
|
2021
Q4 | $18.6M | Buy |
+2,305,017
| New | +$18.6M | 7.73% | 2 |
|